Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hricak

Showing results (441-450 of 565) with videos related to

Pageof 57
Sort By:
The Lancet. Oncology|January 5, 2025
Advances and challenges in precision imagingHedvig Hricak, Marius E Mayerhoefer, Ken Herrmann, et al.
European Radiology|March 31, 2015
Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRIAndreas M Hötker, Yousef Mazaheri, Junting Zheng, et al.
Radiology|May 28, 2004
Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observationsAmita Shukla-Dave, Hedvig Hricak, Steven C Eberhardt, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|July 15, 2015
Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic MalignanciesYulia Lakhman, Stephanie Nougaret, Maura Miccò, et al.
European Radiology|May 3, 2011
Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary resultsOguz Akin, David H Gultekin, Hebert Alberto Vargas, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2016
Renal cell carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumoursChristoph A Karlo, Lei Kou, Pier Luigi Di Paolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2009
Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profilesAmita Shukla-Dave, Hedvig Hricak, Nicole Ishill, et al.
The Lancet. Oncology|August 8, 2020
Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysisZachary J Ward, Andrew M Scott, Hedvig Hricak, et al.
The Oncologist|August 2, 2019
Improving Cancer Diagnosis and Care: Patient Access to High-Quality Oncologic PathologySharyl J Nass, Michael B Cohen, Ritu Nayar, et al.
World Journal of Radiology|April 12, 2017
Multimodality imaging using proton magnetic resonance spectroscopic imaging and <sup>18</sup>F-fluorodeoxyglucose-positron emission tomography in local prostate cancerAmita Shukla-Dave, Cecilia Wassberg, Darko Pucar, et al.
Pageof 57

Showing results (441-450 of 565) with videos related to

Sort By:
Pageof 57
The Lancet. Oncology|January 5, 2025
Advances and challenges in precision imagingHedvig Hricak, Marius E Mayerhoefer, Ken Herrmann, et al.
European Radiology|March 31, 2015
Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRIAndreas M Hötker, Yousef Mazaheri, Junting Zheng, et al.
Radiology|May 28, 2004
Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observationsAmita Shukla-Dave, Hedvig Hricak, Steven C Eberhardt, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|July 15, 2015
Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic MalignanciesYulia Lakhman, Stephanie Nougaret, Maura Miccò, et al.
European Radiology|May 3, 2011
Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary resultsOguz Akin, David H Gultekin, Hebert Alberto Vargas, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2016
Renal cell carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumoursChristoph A Karlo, Lei Kou, Pier Luigi Di Paolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2009
Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profilesAmita Shukla-Dave, Hedvig Hricak, Nicole Ishill, et al.
The Lancet. Oncology|August 8, 2020
Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysisZachary J Ward, Andrew M Scott, Hedvig Hricak, et al.
The Oncologist|August 2, 2019
Improving Cancer Diagnosis and Care: Patient Access to High-Quality Oncologic PathologySharyl J Nass, Michael B Cohen, Ritu Nayar, et al.
World Journal of Radiology|April 12, 2017
Multimodality imaging using proton magnetic resonance spectroscopic imaging and <sup>18</sup>F-fluorodeoxyglucose-positron emission tomography in local prostate cancerAmita Shukla-Dave, Cecilia Wassberg, Darko Pucar, et al.
Pageof 57